Insmed (INSM) news
Recent news
Maverick adds Meta, Snow, Insm, VMC, PFGC in 2Q: 13F
AInvest Wire · Aug 14, 2026Insmed shares open 31% higher after 2Q results
AInvest Wire · Aug 6, 2026Insmed shares extend climb to 27% in premarket after earnings
Insmed (INSM) shares surged 27% in pre-market trading on August 6, 2026, reaching $116.70, following the first-quarter 2026 financial results . The stock opened at $100.48 and traded between $116.36 and $116.36 before the market opened at 9:30 AM ET. This marked a significant increase from the…
AInvest Wire · Aug 6, 2026Insmed: raises FY 2026 BrinSupri revenue guidance to $1.25 bln - $1.40 bln
Insmed, Inc. (Nasdaq: INSM) has raised its full-year 2026 revenue guidance for BRINSUPRI® (brensocatib) to a range of $1.25 billion to $1.40 billion, reflecting strong performance and continued momentum in the product's commercialization. This marks an upward revision from the previous guidance of…
AInvest Wire · Aug 6, 2026Insmed shares rise 17.9% premarket after Q2 revenue beat
AInvest Wire · Aug 6, 2026Light Horse does not author, endorse or verify the headlines, and their appearance here is not an endorsement of any view they express.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.